Viewing Study NCT03158103


Ignite Creation Date: 2025-12-24 @ 7:10 PM
Ignite Modification Date: 2026-01-05 @ 2:56 AM
Study NCT ID: NCT03158103
Status: COMPLETED
Last Update Posted: 2021-04-30
First Post: 2017-05-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST)
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module